SCHEMBL6925265

SCHEMBL6925265

C=CCC1CC[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@@H]3CC[C@]12C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.48
GPBAR1 Q8TDU6 3/20 0.47
LMNA P02545 3/20 0.47
EPHA2 P29317 2/20 0.47
HSD17B10 Q99714 2/20 0.47
AKR1B10 O60218 1/20 0.47
AKR1B1 P15121 1/20 0.47
EFNA1 P20827 1/20 0.47
PSEN1 P49768 1/20 0.47
PSEN2 P49810 1/20 0.47
APH1B Q8WW43 1/20 0.47
NCSTN Q92542 1/20 0.47
APH1A Q96BI3 1/20 0.47
PSENEN Q9NZ42 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
GRIN1 Q05586 1/20 0.40
GRIN2B Q13224 1/20 0.40
SHBG P04278 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11482161 1.00 CYP19A1 (0.48) CYP19A1GPBAR1LMNAEPHA2HSD17B10
SCHEMBL11327393 1.00 CYP19A1 (0.48) CYP19A1GPBAR1LMNAEPHA2HSD17B10
SCHEMBL11774237 0.87 CYP19A1 (0.46) CYP19A1GPBAR1LMNAEPHA2HSD17B10
SCHEMBL11156713 0.86 CYP19A1 (0.51) CYP19A1GPBAR1LMNAEPHA2HSD17B10
SCHEMBL19625947 0.86 CYP19A1 (0.51) CYP19A1GPBAR1LMNAEPHA2HSD17B10
SCHEMBL29076625 0.85 CYP19A1 (0.44) CYP19A1GPBAR1LMNAEPHA2HSD17B10
SCHEMBL144721 0.83 GRIN1 (0.55) CYP19A1GPBAR1LMNAEPHA2HSD17B10
SCHEMBL29875956 0.83 GRIN1 (0.55) CYP19A1GPBAR1LMNAEPHA2HSD17B10
SCHEMBL20677083 0.83 GRIN1 (0.55) CYP19A1GPBAR1LMNAEPHA2HSD17B10
SCHEMBL350132 0.83 GRIN1 (0.55) CYP19A1GPBAR1LMNAEPHA2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040002483-A1 Use of ester and ether derivatives of 4-hydroxy-19-norandrosterone to increase the level of the anabolic/androgenic hormone 4-hydroxy-19-nortestosterone in humans Paternoster, Mr. Vince 2004-01-01 US disclosed
US-20030199487-A1 Ester and ether derivatives of 4-hydroxytestosterone and a method for the regulation of athletic function in humans Paternoster, Mr. Vince 2003-10-23 US disclosed
US-20030199486-A1 Ester and ether derivatives of 4-hydroxy-19-nortestosterone and a method for the regulation of athletic function in humans NUTRI SPORT PHARMACAL, INC. (US) 2003-10-23 US disclosed
US-4301246-A HYDROXYLATION OF 3-KETO-BISNORCHOLENOL TO 7-HYDROXY-3-KETO-BISNORCHOLENOL HOFFMANN-LA ROCHE INC. (US) 1981-11-17 US disclosed
US-4230625-A DISSOLVING GALLSTONES HOFFMANN-LA ROCHE INC. (US) 1980-10-28 US disclosed